Skip to content

Astrazeneca announces forxiga® will be listed on the pbs for Australians living with symptomatic heart failure with reduced ejection fraction

By Gold Cross - December 21, 2021

This article is only available to ITK members and is restricted for Pharmacists. Please or Register as a Pharmacist to read the content.
Share this article:
Article tags

Articles you might be interested in

Pharmacist Only
,

AIHW releases 2022 report card on the health of Australians

Gold Cross | July 7, 2022
,

New study reveals four out of five people with diabetes experience stigma as expert call for more screening

Gold Cross | July 6, 2022
,

Cheers! Here’s to the health-conscious youth:
an untapped drinks market for restaurants

Gold Cross | July 6, 2022

Aussies smash 300,000 heart health check milestone

Gold Cross | July 6, 2022
Experience the BD Rowa Advantage

Latest Posts

Pharmacist Only
AIHW releases 2022 report card on the health of Australians
Gold Cross | July 7, 2022
New study reveals four out of five people with diabetes experience stigma as expert call for more screening
Gold Cross | July 6, 2022
Cheers! Here’s to the health-conscious youth:
an untapped drinks market for restaurants
Gold Cross | July 6, 2022

Featured Posts

A spoonful of castor oil?
Gold Cross | July 4, 2022
Planning For Change
Gold Cross | June 21, 2022
BD Rowa™ is Your Partner for A Bespoke Design Process
Gold Cross | June 7, 2022

Tags

Scroll To Top